Consensus development conference on antipsychotic drugs and obesity and diabetes

J Clin Psychiatry. 2004 Feb;65(2):267-72. doi: 10.4088/jcp.v65n0219.
No abstract available

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / classification
  • Antipsychotic Agents / therapeutic use
  • Causality
  • Comorbidity
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 / chemically induced*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / prevention & control
  • Drug Monitoring
  • Follow-Up Studies
  • Humans
  • Hypercholesterolemia / chemically induced
  • Hypercholesterolemia / epidemiology
  • Hypertriglyceridemia / chemically induced
  • Hypertriglyceridemia / epidemiology
  • Obesity / chemically induced*
  • Obesity / epidemiology
  • Obesity / prevention & control
  • Prediabetic State / chemically induced*
  • Prediabetic State / epidemiology
  • Prediabetic State / prevention & control
  • Risk Assessment
  • Schizophrenia / drug therapy*
  • Schizophrenia / epidemiology

Substances

  • Antipsychotic Agents